Screener
AbCellera Biologics Inc. ABCL Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.4B.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
FAQ
- What is AbCellera Biologics Inc.'s market capitalization?
- AbCellera Biologics Inc. (ABCL) reported market capitalization of $2.4B in Q2 2026.
- How has AbCellera Biologics Inc.'s market capitalization changed year-over-year?
- AbCellera Biologics Inc.'s market capitalization increased by 118.2% year-over-year, from $1.1B to $2.4B.
- What is the long-term trend for AbCellera Biologics Inc.'s market capitalization?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s market capitalization has grown at a -38.2% compound annual growth rate (CAGR), from $11.33B to $1.02B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about AbCellera Biologics Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude